News & Views
Lung cancer drug 'could prevent metastases spreading'
Feb 25 2011
Dr Michela Quirino and colleagues from the Catholic University of the Sacred Heart in Rome announced the laboratory news after investigating how zoledronic acid may be able to prevent the cancer from spreading.
Currently, the drug is used to help treat bone metastases but the study suggests it may also be useful in the initial stages of the disease.
Dr Quirino said: "If further studies should confirm a possible anti-metastatic effect of this drug ... it could be introduced in the early management of the disease, even as an adjuvant therapy."
The expert conducted a trial on 41 patients with advanced lung cancer and concluded that the evidence implies zoledronic acid may prevent the metastases from recruiting the blood vessels they need to survive.
Zoledronic acid is also used to treat high levels of calcium in the blood.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria